Imperial College London
Professor Robert Wilkinson

ProfessorRobertWilkinson

Faculty of Medicine, Department of Infectious Disease

Professor in Infectious Diseases
 
 
 
//

Contact

 

r.j.wilkinson Website

 
 
//

Location

 

Commonwealth BuildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Ndiaye:2015:10.1016/S2213-2600(15)00037-5,
author = {Ndiaye, BP and Thienemann, F and Ota, M and Landry, BS and Camara, M and Dieye, S and Dieye, TN and Esmail, H and Goliath, R and Huygen, K and January, V and Ndiaye, I and Oni, T and Raine, M and Romano, M and Satti, I and Sutton, S and Thiam, A and Wilkinson, KA and Mboup, S and Wilkinson, RJ and McShane, H},
doi = {10.1016/S2213-2600(15)00037-5},
journal = {The Lancet Respiratory Medicine},
pages = {190--200},
title = {Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial},
url = {http://dx.doi.org/10.1016/S2213-2600(15)00037-5},
volume = {3},
year = {2015}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Ndiaye,BP
AU  - Thienemann,F
AU  - Ota,M
AU  - Landry,BS
AU  - Camara,M
AU  - Dieye,S
AU  - Dieye,TN
AU  - Esmail,H
AU  - Goliath,R
AU  - Huygen,K
AU  - January,V
AU  - Ndiaye,I
AU  - Oni,T
AU  - Raine,M
AU  - Romano,M
AU  - Satti,I
AU  - Sutton,S
AU  - Thiam,A
AU  - Wilkinson,KA
AU  - Mboup,S
AU  - Wilkinson,RJ
AU  - McShane,H
DO  - 10.1016/S2213-2600(15)00037-5
EP  - 200
PY  - 2015///
SN  - 2213-2600
SP  - 190
TI  - Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial
T2  - The Lancet Respiratory Medicine
UR  - http://dx.doi.org/10.1016/S2213-2600(15)00037-5
UR  - http://hdl.handle.net/10044/1/23868
VL  - 3
ER  -
Download